Skip to main content
Equibles

WOK · WORK Medical Technology Group LTD · Metrics

Track WOK — free

Use WOK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WOK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.15 -0.03 (-2.54%)
Rebalance outlook locked
Market Cap
$5.14M
Shares
4.47M
Volume · Oct 22 25.53K Avg daily vol (3M) 209.22K

WOK metrics

49 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.18
Market cap
$5.18M

Price action

20 metrics
Price change (1W)
-12.3%
Price change (30D)
-37.9%
Price change (3M)
-36.9%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
85.1%
Annualized volatility (3M)
75.2%
Beta
—
RSI (14D)
27.7
Price vs SMA 50
-36.6%
Price vs SMA 200
—
Avg volume (3M)
209,224
Relative volume
0.2
Average dollar volume
$450,317

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
4.47M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 206.8%
P / book
0.2
reciprocal yield 581.3%
FCF yield
-108.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-86.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
17.0%
Operating margin
—
Trailing 12 months
Net margin
-42.0%
Gross profit (TTM)
$1.82M
Operating profit (TTM)
—
Net income (TTM)
−$4.50M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-52.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$903,644.35

Growth

11 metrics
Revenue growth YoY
-14.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$10.72M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+128.1%
Year over year · more shares
Revenue CAGR (3Y)
-20.6%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-14.9%
Return on assets
-9.3%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
—
Free cash flow (TTM)
−$5.62M
Quick ratio
1.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.25M
Total assets
$48.31M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$865,760
Capital expenditures (TTM)
$4.76M
R&D (TTM)
$280,899
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
2.6%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
3
13F filer change QoQ
+1
Institutional ownership
0.2%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+545,200.0%
Holder tenure
1.0
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
3.1%
Latest settlement · 3.1 days to cover
Days to cover
3.1d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1929783 CUSIP G9767H133